Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso
Clinical trial NCT06618885 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06618885
- Sponsor
- European Vaccine Initiative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-01-31
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.